academic article

• "Reply: Improving Insight and Application: A Commentary on the Link between Initial Depression and Anxiety and Long-Term Health Outcomes in Parkinson's Disease Patients"..  Movement disorders clinical practice.  11:1648-1649. 2024
• End-of-Life Health Care Service Use and Cost Among Medicare Decedents With Neurodegenerative Diseases..  Neurology.  103:-. 2024
• Long-Term Dementia Risk in Parkinson Disease..  Neurology.  103:-. 2024
• Improving Parkinson's Disease Care through Systematic Screening for Depression..  Movement disorders clinical practice.  11:1212-1222. 2024
• Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease..  Movement disorders clinical practice.  11:1103-1112. 2024
• Genetic and phenotypic characterization of Parkinson's disease at the clinic-wide level..  NPJ Parkinson's disease.  10:-. 2024
• Novel computerized measure of apathy associates with care partner burden and instrumental activities of daily living in Parkinson's disease..  Parkinsonism & related disorders.  -. 2024
• Ethnoracial differences for caregiving burden in Parkinson's disease..  Parkinsonism & related disorders.  -. 2023
• Unique characteristics of end-of-life hospitalizations in Parkinson disease..  Frontiers in aging neuroscience.  -. 2023
• Association of Caregiver Depression Risk With Patient Outcomes in Parkinson Disease..  JAMA network open.  6:-. 2023
• Validation of the Rainbow Model of Integrated Care Measurement Tool in Parkinson's Disease..  Movement disorders : official journal of the Movement Disorder Society.  38:1253-1261. 2023
• Racial and Ethnic Differences in Health-Related Quality of Life for Individuals With Parkinson Disease Across Centers of Excellence..  Neurology.  100:e2170-e2181. 2023
• Racial and Ethnic Disparities in Parkinson Disease: A Call to Action..  Neurology Clinical Practice.  13:-. 2023
• The Impact of the COVID-19 Pandemic on Care Partners of People with Parkinson's Disease..  Movement disorders clinical practice.  10:596-605. 2023
• Parkinson's Pals: A Student-Led Program to Facilitate Intergenerational Connections and Promote Psychosocial Well-Being Among Persons with Parkinson's Disease..  Journal of Parkinson's disease.  13:1267-1271. 2023
• Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers..  Parkinsonism & related disorders.  33-36. 2022
• Adverse Childhood Experiences in Patients With Neurologic Disease..  Neurology. Clinical practice.  12:60-67. 2022
• Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson's Disease..  Journal of Parkinson's disease.  12:421-436. 2022
• Current Knowledge on the Evolution of Care Partner Burden, Needs, and Coping in Parkinson's Disease..  Movement disorders clinical practice.  8:510-520. 2021
• Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias..  Neurology.  96:e1855-e1864. 2021
• Low Sustainment of High-Dose Oral Medication Regimens for Advanced Parkinson's Disease in Medicare Beneficiaries..  Journal of Parkinson's disease.  11:675-684. 2021
• Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease..  Journal of Parkinson's disease.  11:737-745. 2021
• Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study..  Journal of Parkinson's disease.  11:757-765. 2021
• Overcoming Barriers to Parkinson Disease Trial Participation: Increasing Diversity and Novel Designs for Recruitment and Retention..  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics.  17:1724-1735. 2020
• Tau pathology associates with in vivo cortical thinning in Lewy body disorders..  Annals of clinical and translational neurology.  7:2342-2355. 2020
• Burden of Parkinson's Disease by Severity: Health Care Costs in the U.S. Medicare Population..  Movement disorders : official journal of the Movement Disorder Society.  36:133-142. 2020
• Prospective Home-use Study on Non-invasive Neuromodulation Therapy for Essential Tremor..  Tremor and other hyperkinetic movements (New York, N.Y.).  -. 2020
• Integrated Care in Parkinson's Disease: A Systematic Review and Meta-Analysis..  Movement disorders : official journal of the Movement Disorder Society.  35:1509-1531. 2020
• Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?.  Movement disorders : official journal of the Movement Disorder Society.  35:1618-1625. 2020
• Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity..  Clinical parkinsonism & related disorders.  -. 2020
• Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience..  Journal of Parkinson's disease.  10:665-675. 2020
• Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis..  Muscle & nerve.  61:508-511. 2019
• Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies..  Parkinsonism & related disorders.  119-124. 2019
• Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants..  Movement disorders clinical practice.  6:440-445. 2019
• Quality of education impacts late-life cognition..  International journal of geriatric psychiatry.  34:855-862. 2019
• Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients..  Neurology.  92:e9-e18. 2018
• Pharmacological treatment of apathy in Lewy body disorders: A systematic review..  Parkinsonism & related disorders.  14-24. 2018
• Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health..  NPJ Parkinson's disease.  -. 2018
• Sex disparities in health and health care utilization after Parkinson diagnosis: Rethinking PD associated disability..  Parkinsonism & related disorders.  45-50. 2017
• Sex disparities in access to caregiving in Parkinson disease..  Neurology.  90:e48-e54. 2017
• APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease..  Movement disorders : official journal of the Movement Disorder Society.  33:289-297. 2017
• Utilization of rehabilitation therapy services in Parkinson disease in the United States..  Neurology.  89:1162-1169. 2017
• Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental Study..  Health services research.  53 Suppl 1:2735-2757. 2017
• Postdiagnosis neurological care for patients with psychogenic nonepileptic spells (PNES)..  Epilepsy & behavior : E&B.  64-68. 2017
• Longitudinal decline in speech production in Parkinson's disease spectrum disorders..  Brain and language.  42-51. 2017
• Parkinsonian signs are a risk factor for falls..  Gait & posture.  1-5. 2017
• Improved availability and quality of care with epilepsy nurse practitioners..  Neurology. Clinical practice.  7:109-117. 2017
• Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis..  Journal of Parkinson's disease.  7:385-395. 2017
• Statins and Cognition in Parkinson's Disease..  Journal of Parkinson's disease.  7:661-667. 2017
• Prevalence and Correlates of Anti-Parkinson Drug Use in a Nationally Representative Sample..  Movement disorders clinical practice.  4:335-341. 2016
• Computerized assessment of goal-directed behavior in Parkinson's disease..  Journal of clinical and experimental neuropsychology.  38:1015-25. 2016
• Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease..  Journal of neurology, neurosurgery, and psychiatry.  87:1303-1310. 2016
• Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx)..  Journal of Parkinson's disease.  6:383-92. 2016
• The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease..  Parkinsonism & related disorders.  21-6. 2016
• Associations and implications of low health literacy in Parkinson's Disease..  Movement disorders clinical practice.  3:250-256. 2015
• Longitudinal study of normal cognition in Parkinson disease..  Neurology.  85:1276-82. 2015
• Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire..  Movement disorders : official journal of the Movement Disorder Society.  31:126-34. 2015
• Caregiver report of apathy predicts dementia in Parkinson's disease..  Parkinsonism & related disorders.  21:992-5. 2015
• Analysis of the treatment of neuromyelitis optica..  Journal of the neurological sciences.  351:31-35. 2015
• Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial..  JAMA.  313:584-93. 2015
• Knowledge and attitudes about Parkinson's disease among a diverse group of older adults..  Journal of cross-cultural gerontology.  29:339-52. 2014
• Surface EMG activity during REM sleep in Parkinson's disease correlates with disease severity..  Parkinsonism & related disorders.  20:766-71. 2014
• Health literacy and medication awareness in outpatient neurology..  Neurology. Clinical practice.  4:71-81. 2014
• Utilization of care among drug resistant epilepsy patients with symptoms of anxiety and depression..  Seizure.  23:196-200. 2013
• Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease..  Parkinsonism & related disorders.  19:859-63. 2013
• Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease..  Movement disorders : official journal of the Movement Disorder Society.  28:1146-9. 2013
• Daytime sleepiness is associated with falls in Parkinson's disease..  Journal of Parkinson's disease.  3:387-91. 2013
• Can a screening questionnaire accurately identify mild Parkinsonian signs?.  Neuroepidemiology.  39:171-5. 2012
• Validation of an instrument to measure older adults' expectations regarding movement (ERM)..  PloS one.  7:-. 2012
• Genetic influences on cognitive decline in Parkinson's disease..  Movement disorders : official journal of the Movement Disorder Society.  27:512-8. 2012
• Screening questionnaires for parkinsonism: a systematic review..  Parkinsonism & related disorders.  18:216-24. 2011
• Emerging subspecialties in neurology: health services research..  Neurology.  74:e37-9. 2010
• Treatment disparities in Parkinson's disease..  Annals of neurology.  66:142-5. 2009
• Racial differences in the diagnosis of Parkinson's disease..  Movement disorders : official journal of the Movement Disorder Society.  24:1200-5. 2009
• Prevalence of sexually transmitted infections and high-risk sexual behaviors in heterosexual couples attending sexually transmitted disease clinics in Peru..  Sexually transmitted diseases.  34:344-61. 2007
• Teaching: residents in the hospital, mentors in the community: the Educational Pipeline Program at Penn..  Neurology.  68:E25-8. 2007
• Neurology education and global health: my rotation in Botswana..  Neurology.  68:E15-6. 2007